LY3114062

LY3114062 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3114062, covering 2015-07-17 to 2015-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis [Phase 1]